The Department of Health of China has asked Hong Kong Dongxingtang Technology Development Co., Ltd (Dongxingtang) and Kwok Shing Hong Medicine Co., Ltd (Kwok Shing Hong) to voluntarily produce medicinal products including Fructus Corni (lot number 20180301) and Rhizoma Alismatis (lot number 63022110).Fructus Corni and Rhizoma Alismatis is used for Hyperglycemia, dyslipidemia, oxidative stress, hypercholesterolemia and other conditions.Fructus Corni and Rhizoma Alismatis with the main ingredients being vermilion and zebraDuring testing, each kilogram of Fructus Corni was detected to contain 0.14 mg of triazophos;Each kg of Rhizoma Alismatis contains 0.26 mg of triazophos and 0.15 mg of chlorpyrifos.According to the regulations of the Chinese Medical Council, triazophos and chlorpyrifos are substances that are not allowed to be used in drug preparation.Triazophos and chlorpyrifos are organophosphate-based insecticide compounds.If these substances enter the body, it will cause symptoms such as runny nose, watery eyes and increased salivation.More severe exposure may cause vomiting, abdominal cramps, muscle twitching.More severe cases can cause diarrhea or temporary blurred vision or blindness.In cases of severe poisoning, the person may lose consciousness, lose bladder and bowel control, convulsions, difficulty breathing, and paralysis.A spokesman for China's Ministry of Health said, "Based on the level of pesticide residues detected in the samples, there should be no adverse health effects when used in the correct dosage.However, long-term use of triazophos or chlorpyrifos can have adverse health effects.To date, there have not been any unfortunate cases related to these two drugs.Investigations are underway.”Under section 52 of the Municipal Services and Public Health Ordinance, any person or organization selling substandard drugs will be subject to a maximum fine of $10,000 and three months in prison.After completing the investigation, the Chinese Department of Health will work with the Ministry of Justice to prosecute relevant parties.The Chinese Department of Health recommends that consumers stop using these medicinal products immediately.If there are health problems, the patient needs to go to the hospital to receive timely support.Copyright belongs to Creative and Intellectual Property Magazine, any reproduction must be approved in writing by Intellectual Property and Creative Journal.Editor-in-Chief: Luong Hoang HungDeputy Editor-in-Chief: Nguyen Van Khanh (Duy Khanh)Deputy Editor-in-Chief: Dinh Quang TuanElectronic newspaper license number: 347/GP-BTTTT of the Ministry of Information and Communications.ISSN: 2354-1458.Editorial office: B82 Bach Dang, ward 2, Tan Binh district, HCMC.Hotline: 0777077749. Email: [email protected] - Communication cooperation: 0965 001 777 - Mr.Kim Dong.In Hanoi: 1A Xuan La Street, Xuan La, Tay Ho District, City.Hanoi.Tel: 0919 880 866.